Therapeutic levels of erythropoietin (EPO) achieved after gene electrotransfer to skin in mice

Gene Therapy

Volumn 17, Issue 9, 2010, Pages 1077-1084

  Gothelf, A ^a   Hojman, P ^a,b   Gehl, J ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b Mental Health Services CPH   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CMV LUC; DNA; ERYTHROPOIETIN; HEMOGLOBIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; ELECTRODE; ELECTROPORATION; FEMALE; MOUSE; NEOPLASM; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SKIN;

MUS;

EID: 77956618197     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2010.46     Document Type: Article

References (44)

1. Kohn DB, Candotti F. Gene therapy fulfilling its promise. N Engl J Med 2009; 360: 518–521.
2. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A et al. Direct gene transfer into mouse muscle in vivo. Science 1990; 247 (4949 Part 1): 1465–1468.
3. Hengge UR, Chan EF, Foster RA, Walker PS, Vogel JC. Cytokine gene expression in epidermis with biological effects following injection of naked DNA. Nat Genet 1995; 10: 161–166.
4. Nicolau C, Le PA, Soriano P, Fargette F, Juhel MF. In vivo expression of rat insulin after intravenous administration of the liposome-entrapped gene for rat insulin I. Proc Natl Acad Sci USA 1983; 80: 1068–1072.
5. Alexander MY, Akhurst RJ. Liposome-medicated gene transfer and expression via the skin. Hum Mol Genet 1995; 4: 2279–2285.
6. Yang NS, Burkholder J, Roberts B, Martinell B, McCabe D. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc Natl Acad Sci USA 1990; 87: 9568–9572.
7. Mavilio F, Pellegrini G, Ferrari S, Di NF, Di IE, Recchia A et al. Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med 2006; 12: 1397–1402.
8. Lucas ML, Heller L, Coppola D, Heller R. IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma. Mol Ther 2002; 5: 668–675.
9. McCray AN, Ugen KE, Heller R. Enhancement of anti-melanoma activity of a plasmid expressing HIV-1 Vpr delivered through in vivo electroporation. Cancer Biol Ther 2007; 6: 1269–1275.
10. Hojman P, Gissel H, Gehl J. Sensitive and precise regulation of haemoglobin after gene transfer of erythropoietin to muscle tissue using electroporation. Gene Therapy 2007; 14: 950–959.
11. Trochon-Joseph V, Martel-Renoir D, Mir LM, Thomaidis A, Opolon P, Connault E et al. Evidence of antiangiogenic and antimetastatic activities of the recombinant disintegrin domain of metargidin. Cancer Res 2004; 64: 2062–2069.
12. Mir LM, Moller PH, Andre F, Gehl J. Electric pulse-mediated gene delivery to various animal tissues. In: Huang L, Hung MC, Wagner E, (eds). Nonviral Vectors for Gene Therapy, Part II. 2nd edn. Elsevier Academic Press: San Diego, CA, USA, 2005. pp. 83–114.
13. Cemazar M, Sersa G. Electrotransfer of therapeutic molecules into tissues. Curr Opin Mol Ther 2007; 9: 554–562.
14. Bodles-Brakhop AM, Heller R, Draghia-Akli R. Electroporation for the delivery of DNA-based vaccines and immunotherapeu-tics: current clinical developments. Mol Ther 2009; 17: 585–592.
15. Muramatsu T, Arakawa S, Fukazawa K, Fujiwara Y, Yoshida T, Sasaki R et al. In vivo gene electroporation in skeletal muscle with special reference to the duration of gene expression. Int J Mol Med 2001; 7: 37–42.
16. Drabick JJ, Glasspool-Malone J, King A, Malone RW. Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermea-bilization. Mol Ther 2001; 3: 249–255.
17. Roos AK, Moreno S, Leder C, Pavlenko M, King A, Pisa P. Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation. Mol Ther 2006; 13: 320–327.
18. Dobano C, Widera G, Rabussay D, Doolan DL. Enhancement of antibody and cellular immune responses to malaria DNA vaccines by in vivo electroporation. Vaccine 2007; 25: 6635–6645.
19. Zhang L, Li L, Hoffmann GA, Hoffman RM. Depth-targeted efficient gene delivery and expression in the skin by pulsed electric fields: an approach to gene therapy of skin aging and other diseases. Biochem Biophys Res Commun 1996; 220: 633–636.
20. Glasspool-Malone J, Somiari S, Drabick JJ, Malone RW. Efficient nonviral cutaneous transfection. Mol Ther 2000; 2: 140–146.
21. Pavselj N, Preat V. DNA electrotransfer into the skin using a combination of one high-and one low-voltage pulse. J Control Release 2005; 106: 407–415.
22. Heller LC, Jaroszeski MJ, Coppola D, McCray AN, Hickey J, Heller R. Optimization of cutaneous electrically mediated plasmid DNA delivery using novel electrode. Gene Therapy 2007; 14: 275–280.
23. Lee PY, Chesnoy S, Huang L. Electroporatic delivery of TGF-beta1 gene works synergistically with electric therapy to enhance diabetic wound healing in db/db mice. J Invest Dermatol 2004; 123: 791–798.
24. Lin MP, Marti GP, Dieb R, Wang J, Ferguson M, Qaiser R et al. Delivery of plasmid DNA expression vector for keratinocyte growth factor-1 using electroporation to improve cutaneous wound healing in a septic rat model. Wound Repair Regen 2006; 14: 618–624.
25. Maruyama H, Ataka K, Higuchi N, Sakamoto F, Gejyo F, Miyazaki J. Skin-targeted gene transfer using in vivo electroporation. Gene Therapy 2001; 8: 1808–1812.
26. Gothelf A, Hojman P, Gehl J. Change in hemoglobin levels due to anesthesia in mice; an important confounder in studies on hematopoietic drugs. Biol Proced Online 2009; 11: 325–330.
27. Pagel H, Engel A, Jelkmann W. Erythropoietin induction by hypoxia. A comparison of in vitro and in vivo experiments. Adv Exp Med Biol 1992; 317: 515–519.
28. Whelan G, Flecknell PA. The use of etorphine/methotrimepra-zine and midazolam as an anaesthetic technique in laboratory rats and mice. Lab Anim 1994; 28: 70–77.
29. Andre FM, Gehl J, Sersa G, Preat V, Hojman P, Eriksen J et al. Efficiency of high-and low-voltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and skin. Hum Gene Ther 2008; 19: 1261–1272.
30. Lezon CE, Martinez MP, Conti MI, Bozzini CE. Plasma disappearance of exogenous erythropoietin in mice under different experimental conditions. Endocrine 1998; 8: 331–333.
31. Bugelski PJ, Nesspor T, Volk A, O’Brien J, Makropoulos D, Shamberger K et al. Pharmacodynamics of recombinant human erythropoietin in murine bone marrow. Pharm Res 2008; 25: 369–378.
32. Galson DL, Tan CC, Ratcliffe PJ, Bunn HF. Comparison of the human and mouse erythropoietin genes shows extensive homology in the flanking regions. Blood 1993; 82: 3321–3326.
33. Wen D, Boissel JP, Tracy TE, Gruninger RH, Mulcahy LS, Czelusniak J et al. Erythropoietin structure-function relationships: high degree of sequence homology among mammals. Blood 1993; 82: 1507–1516.
34. McMahon FG, Vargas R, Ryan M, Jain AK, Abels RI, Perry B et al. Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injections in healthy volunteers. Blood 1990; 76: 1718–1722.
35. Woo S, Krzyzanski W, Jusko WJ. Pharmacokinetic and pharma-codynamic modeling of recombinant human erythropoietin after intravenous and subcutaneous administration in rats. J Pharmacol Exp Ther 2006; 319: 1297–1306.
36. Magnani M, Rossi L, Stocchi V, Cucchiarini L, Piacentini G, Fornaini G. Effect of age on some properties of mice erythrocytes. Mech Ageing Dev 1988; 42: 37–47.
37. Hoffmann-Fezer G, Mysliwietz J, Mortlbauer W, Zeitler HJ, Eberle E, Honle U et al. Biotin labeling as an alternative nonradioactive approach to determination of red cell survival. Ann Hematol 1993; 67: 81–87.
38. Gothelf A, Eriksen J, Hojman P, Gehl J. Duration and level of transgene expression after gene electrotransfer to skin in mice. Gene Therapy 2009; Accepted for publication.
39. Medi BM, Hoselton S, Marepalli RB, Singh J. Skin targeted DNA vaccine delivery using electroporation in rabbits. I: efficacy. Int J Pharm 2005; 294: 53–63.
40. Daud AI, DeConti RC, Andrews S, Urbas P, Riker AI, Sondak VK et al. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol 2008; 26: 5896–5903.
41. Ferraro B, Cruz YL, Coppola D, Heller R. Intradermal delivery of plasmid VEGF(165) by electroporation promotes wound healing. Mol Ther 2009; 17: 651–657.
42. Kistner A, Gossen M, Zimmermann F, Jerecic J, Ullmer C, Lubbert H et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 1996; 93: 10933–10938.
43. Rizzuto G, Cappelletti M, Maione D, Savino R, Lazzaro D, Costa P et al. Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation. Proc Natl Acad Sci USA 1999; 96: 6417–6422.
44. Hojman P, Eriksen J, Gehl J. Tet-On Induction with Doxycycline after Gene Transfer in Mice: Sweetening of Drinking Water is not a Good Idea. Anim Biotechnol 2007; 18: 183–188.